THE IMPACT OF A BREAST-CANCER SCREENING-PROGRAM ON QUALITY-ADJUSTED LIFE-YEARS

被引:111
作者
DEHAES, JCJM
DEKONING, HJ
VANOORTMARSSEN, GJ
VANAGT, HME
DEBRUYN, AE
van der Maas, PJ
机构
[1] ERASMUS UNIV, DEPT PUBL HLTH & SOCIAL MED, POB 1738, 3000 DR ROTTERDAM, NETHERLANDS
[2] UNIV HOSP AMSTERDAM, DEPT MED PSYCHOL, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
10.1002/ijc.2910490411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Trials have shown that breast cancer screening is effective in reducing breast cancer mortality and gaining life-years. The question is whether taking into account the impact of a screening programme on quality of life would lead to a less positive view. Screening may have effects on quality of life in the short run for women participating and effects in the long run as a result of the expected shift in the number of women experiencing early and advanced phases of the disease, after the initiation of the programme. In this study 4 steps ave been taken: (1) published studies on quality of life and breast cancer (screening) up to 1989 have been reviewed and summarized and, based on these data, the consequences of breast cancer and treatment have been described; (2) values have been assigned to the disease and treatment phases by experts in breast cancer and public health (N = 31, response 87%); (3) these values have been inserted in the MISCAN model predicting the prevalence Of disease/treatment phases with and without a 2-yearly screening programme for women aged 50-70 and multiplied by the duration of these phases; (4) analyses have been done to establish the sensitivity of the results for the values inserted. The programme of 2-yearly mammographic screening for women aged 50-70 is predicted to be 8% "less effective" (range - 19.7 to +3.2%) when computing quality-adjusted life-years. We conclude that this adjustment is too small to attribute a major role to quality of life in the decision to undertake a large-scale breast cancer screening programme.
引用
收藏
页码:538 / 544
页数:7
相关论文
共 24 条
[1]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[2]  
BUXTON M, 1987, 3RD ANN M INT SOC TE
[3]   PSYCHIATRIC MORBIDITY AFTER SCREENING FOR BREAST-CANCER [J].
DEAN, C ;
ROBERTS, MM ;
FRENCH, K ;
ROBINSON, S .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1986, 40 (01) :71-75
[4]   QUALITY OF LIFE INSTRUMENTS FOR CANCER-PATIENTS - BABEL TOWER REVISITED [J].
DEHAES, JCJM ;
VANKNIPPENBERG, FCE .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (12) :1239-1241
[5]   BREAST-CANCER SCREENING AND COST-EFFECTIVENESS - POLICY ALTERNATIVES, QUALITY-OF-LIFE CONSIDERATIONS AND THE POSSIBLE IMPACT OF UNCERTAIN FACTORS [J].
DEKONING, HJ ;
VANINEVELD, BM ;
VANOORTMARSSEN, GJ ;
DEHAES, JCJM ;
COLLETTE, HJA ;
HENDRIKS, JHCL ;
VANDERMAAS, P .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (04) :531-537
[6]   BREAST-CANCER SCREENING - ITS IMPACT ON CLINICAL MEDICINE [J].
DEKONING, HJ ;
VANOORTMARSSEN, GJ ;
VANINEVELD, BM ;
van der Maas, PJ .
BRITISH JOURNAL OF CANCER, 1990, 61 (02) :292-297
[7]   A PILOT-STUDY OF ATTENDANCE FOR BREAST-CANCER SCREENING [J].
EARDLEY, A ;
ELKIND, A .
SOCIAL SCIENCE & MEDICINE, 1990, 30 (06) :693-699
[8]   PSYCHIATRIC MORBIDITY ASSOCIATED WITH SCREENING FOR BREAST-CANCER [J].
ELLMAN, R ;
ANGELI, N ;
CHRISTIANS, A ;
MOSS, S ;
CHAMBERLAIN, J ;
MAGUIRE, P .
BRITISH JOURNAL OF CANCER, 1989, 60 (05) :781-784
[9]   PSYCHOLOGICAL OUTCOMES OF DIFFERENT TREATMENT POLICIES IN WOMEN WITH EARLY BREAST-CANCER OUTSIDE A CLINICAL-TRIAL [J].
FALLOWFIELD, LJ ;
HALL, A ;
MAGUIRE, GP ;
BAUM, M .
BRITISH MEDICAL JOURNAL, 1990, 301 (6752) :575-580
[10]  
FORREST P, 1986, BREAST CANCER SCREEN